ProPublica: 10 drugs with the highest physician payments from companies
ProPublica updated its Dollars for Docs database that features payments companies made to physicians from August 2013 through December 2015.
Dollars for Docs lists the following 10 drugs for which companies paid the most in payments to physicians last year:
1. Xarelto (a blood thinner) — $28.4 million
2. Humira (rheumatoid arthritis drug) — $24.9 million
3. Invokana (drug for diabetes) — $20.9 million
4. Viekira (hepatitis C drug) — $19.2 million
5. Eliquis (blood thinner) — $18.8 million
6. Bydureon (diabetes drug) — $18.5 million
7. Androgel (testosterone drug)— $15.3 million
8. Synthroid (thyroid drug)—$14.7 million
9. Lupron (synthetic hormone) — $14.3 million
10. Victoza (diabetes drug)— $11.9 million
More articles on quality & infection control:
The Joint Commission addresses confusion surrounding provider text messaging: 5 things to know
Global disposable syringes market to surge to $9.9B by 2024: 4 points
Study: '32k fewer patients would die every year if male physicians could achieve the same outcomes as female physicians'
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- Non-Medicaid expansion states could gain up to $27.9B in savings by expanding program: 4 takeaways
- Senate committee advances vote on Trump's FDA pick Dr. Scott Gottlieb
- GI leader to know: Dr. Michael Sagatelian of Palmetto Digestive Health Specialists
- Drs. Todd Baron & Kevin Collier: 2 GI physicians in the headlines
- New Century Spine and Outpatient Surgical Institute installs Indigo-Clean disinfecting lights